Handelsbanken Fonder’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-54,300
| Closed | -$835K | – | 1505 |
|
|
2025
Q4 | $835K | Buy |
54,300
+12,800
| +31% | +$141K | ﹤0.01% | 1116 |
|
|
2025
Q3 | $412K | Hold |
41,500
| – | – | ﹤0.01% | 1338 |
|
|
2025
Q2 | $412K | Sell |
41,500
-8,200
| -16% | -$86.4K | ﹤0.01% | 1321 |
|
|
2025
Q1 | $645K | Hold |
49,700
| – | – | ﹤0.01% | 1138 |
|
|
2024
Q4 | $635K | Buy |
49,700
+4,300
| +9% | +$52K | ﹤0.01% | 1192 |
|
|
2024
Q3 | $506K | Hold |
45,400
| – | – | ﹤0.01% | 1236 |
|
|
2024
Q2 | $510K | Buy |
45,400
+18,100
| +66% | +$211K | ﹤0.01% | 1148 |
|
|
2024
Q1 | $339K | Hold |
27,300
| – | – | ﹤0.01% | 1340 |
|
|
2023
Q4 | $382K | Buy |
27,300
+900
| +3% | +$12.5K | ﹤0.01% | 1280 |
|
|
2023
Q3 | $390K | Hold |
26,400
| – | – | ﹤0.01% | 1185 |
|
|
2023
Q2 | $341K | Hold |
26,400
| – | – | ﹤0.01% | 1280 |
|
|
2023
Q1 | $259K | Buy |
26,400
+4,900
| +23% | +$52.3K | ﹤0.01% | 1352 |
|
|
2022
Q4 | $229K | Hold |
21,500
| – | – | ﹤0.01% | 1382 |
|
|
2022
Q3 | $224K | Hold |
21,500
| – | – | ﹤0.01% | 1396 |
|
|
2022
Q2 | $271K | Hold |
21,500
| – | – | ﹤0.01% | 1381 |
|
|
2022
Q1 | $233K | Hold |
21,500
| – | – | ﹤0.01% | 1602 |
|
|
2021
Q4 | $303K | Buy |
+21,500
| New | +$354K | ﹤0.01% | 1610 |
|
Other funds holding DVAX
Handelsbanken Fonder's DVAX Position: Q1 2026 in Review
Handelsbanken Fonder sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 54,300 shares — an estimated $835K sold.
Handelsbanken Fonder first reported a position in DVAX in Q4 2021 and held it in 17 quarters. The position peaked at $835K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Handelsbanken Fonder reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Handelsbanken Fonder sold 54,300 Dynavax Technologies shares in Q1 2026, an estimated $835K.
- Handelsbanken Fonder first reported a position in Dynavax Technologies in Q4 2021 and held it in 17 quarters.
- Handelsbanken Fonder's Dynavax Technologies position peaked at $835K in Q4 2025.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Handelsbanken Fonder's 13F filing for Q1 2026, filed 28 Apr 2026.